Site icon pharmaceutical daily

North America Pharmaceutical Contract Manufacturing Market is Expected to Reach $62.8 Billion by 2030 – ResearchAndMarkets.com

BusinessWire

DUBLIN–(BUSINESS WIRE)–The “North America Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

North America pharmaceutical contract manufacturing market is expected to grow by 5.4% annually in the forecast period and reach $62.8 billion by 2030 driven by rising need for medicines amid COVID-19 pandemic and increasing dependence on contract manufacturing organizations due to improved efficiency and productivity.

This report is based on a comprehensive research of the entire North America pharmaceutical contract manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical contract manufacturing market in every aspect of the classification from perspectives of Category, Product, Phase, Type, Therapeutic Application, and Country.

(Read more…)

Key Players

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Five Forces Analysis

3 Segmentation of North America Market by Category

3.1 Market Overview by Category

3.2 Pharmaceutical Industry

3.3 Biopharmaceutical Industry

4 Segmentation of North America Market by Product

4.1 Market Overview by Product

4.2 Active Pharmaceutical Ingredients (API)

4.2.1 Branded API Manufacturing

4.2.2 Generic API Manufacturing

4.3 Finished Dosage Formulations (FDF)

4.3.1 Solid Dosage

4.3.2 Oral Liquids

4.3.3 Parenteral/Injectables

4.3.4 Other FDFs

4.4 Secondary Packaging

5 Segmentation of North America Market by Phase

5.1 Market Overview by Phase

5.2 Clinical Manufacturing

5.3 Commercial Manufacturing

6 Segmentation of North America Market by Type

6.1 Market Overview by Type

6.2 Sterile Products

6.3 Non-Sterile Products

7 Segmentation of North America Market by Therapeutic Application

7.1 Market Overview by Therapeutic Application

7.2 Infectious Diseases

7.3 Oncology

7.4 Metabolic Disorders

7.5 Cardiovascular Disorders

7.6 Central Nervous System

7.7 Pulmonary Disorders

7.8 Gastrointestinal Disorders

7.9 Other Therapeutic Applications

8 North America Market 2019-2030 by Country

8.1 Overview of North America Market

8.2 U.S.

8.3 Canada

8.4 Mexico

9 Competitive Landscape

9.1 Overview of Key Vendors

9.2 New Product Launch, Partnership, Investment, and M&A

9.3 Company Profiles

10 Investing in North America Market: Risk Assessment and Management

10.1 Risk Evaluation of North America Market

10.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/hkcqk9

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version